Key Market Indicators
French pharmaceutical production has experienced a significant decline in 2023, falling to approximately €223 million. This marks a 35.2% decrease from 2022's production value of around €344 million. Over the past decade, French pharmaceutical supply has been on a downward trajectory, decreasing by an average of 20.8% year on year since 2013. In the latest rankings for 2023, France has slipped to the 11th position. Portugal has overtaken France, matching its €223 million production. Italy, Spain, and Austria have secured the 2nd, 3rd, and 4th positions, respectively, in the European pharmaceutical production rankings.
Latest reports
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
France Pharmaceuticals Market Report - Q4 2024
The French pharmaceuticals market in Q4 2024 is characterized by dynamic shifts driven by economic, regulatory, and consumer trends. Key segments such as...
